Oxford Endovascular is a medical device company that develops advanced neurovascular technologies for patients with brain aneurysms. It offers OxiFlow, a novel flow-diverter that diverts blood flow away from intracranial aneurysms at risk of rupture, places more accurately and safely reducing the risk of complications, and conforms better to blood vessels making more patients treatable. The company focuses on brain hemorrhage prevention to address unmet clinical needs.